Influence of prophylactic, endovascularly based normothermia on inflammation in patients with severe cerebrovascular disease: A prospective, randomized trial

Stroke

Volumn 41, Issue 12, 2010, Pages 2969-2972

  Broessner, Gregor ^a   Lackner, Peter ^a   Fischer, Marlene ^a   Beer, Ronny ^a   Helbok, Raimund ^a   Pfausler, Bettina ^a   Schneider, Dietmar ^b   Schmutzhard, Erich ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

endovascular cooling; inflammation; nonsteroidal antiinflammatory drugs; normothermia; stroke

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BODY TEMPERATURE; BRAIN HEMORRHAGE; CATHETER; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; FEVER; GLASGOW COMA SCALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BODY TEMPERATURE; C-REACTIVE PROTEIN; CEREBROVASCULAR DISORDERS; FEMALE; FEVER; HUMANS; INFLAMMATION; INTENSIVE CARE; INTERLEUKIN-10; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 78650419080     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.591933     Document Type: Article

References (13)

1. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke. 1998;29:529-534.
2. Badjatia N. Hyperthermia and fever control in brain injury. Crit Care Med. 2009;37:S250-S257.
3. Kollmar R, Schabitz WR, Heiland S, Georgiadis D, Schellinger PD, Bardutzky J, Schwab S. Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study. Stroke. 2002; 33:1899-1904.
4. Yanamoto H, Nagata I, Nakahara I, Tohnai N, Zhang Z, Kikuchi H. Combination of intraischemic and postischemic hypothermia provides potent and persistent neuroprotection against temporary focal ischemia in rats. Stroke. 1999;30:2720-2726.
5. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, Kuppers-Tiedt L, Schneider D, Schmutzhard E. Prophylactic, endovas-cularly based, long-term normothermia in ICU patients with severe cere-brovascular disease: bicenter prospective, randomized trial. Stroke. 2009; 40:e657-e665.
6. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith Jr. KR, Muizelaar JP, Wagner Jr. FC, Marion DW, Luerssen TG, Chesnut RM, Schwartz M. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001;344:556-563.
7. Bernard S. Hypothermia after cardiac arrest: expanding the therapeutic scope. Crit Care Med. 2009;37:S227-S233.
8. Polderman KH. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet. 2008;371:1955-1969.
9. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37:S186-S202.
10. Polderman KH, Herold I. Therapeutic hypothermia and controlled nor-mothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37:1101-1120.
11. Schmutzhard E, Engelhardt K, Beer R, Brossner G, Pfausler B, Spiss H, Unterberger I, Kampfl A. Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med. 2002;30:2481-2488.
12. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002;22:1399-1419.
13. Den Hertog HM, Van Der Worp HB, Van Gemert HM, Algra A, Kappelle LJ, Van Gijn J, Koudstaal PJ, Dippel DW. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009;8:434-440.